Cargando…
Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma
BACKGROUND: There is growing evidence that pseudogenes may serve as prognostic biomarkers in several cancers. The present study was designed to develop and validate an accurate and robust pseudogene pairs-based signature for the prognosis of hepatocellular carcinoma (HCC). METHODS: RNA-sequencing da...
Autores principales: | Du, Yajuan, Gao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493157/ https://www.ncbi.nlm.nih.gov/pubmed/32938429 http://dx.doi.org/10.1186/s12885-020-07391-2 |
Ejemplares similares
-
Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma
por: Kang, Chunmiao, et al.
Publicado: (2020) -
A pseudogene-signature in glioma predicts survival
por: Gao, Kai-Ming, et al.
Publicado: (2015) -
Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma
por: Zhao, Enfa, et al.
Publicado: (2021) -
A novel m6A‐related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients
por: Xie, Shiyang, et al.
Publicado: (2021) -
A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer
por: Fu, Yang, et al.
Publicado: (2021)